Inventor
ISHIGURO TAKAHIRO
JP12 patents
⚠️ This page may combine multiple inventors who share the name “ISHIGURO TAKAHIRO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CHUGAI PHARMACEUTICAL CO LTD
10 patentsUS7919086B2Apr 5, 2011
Anti-glypican 3 antibody
CHUGAI PHARMACEUTICAL CO LTD74 citations96
US9975966B2May 22, 2018
Cytotoxicity-inducing theraputic agent
CHUGAI PHARMACEUTICAL CO LTD25 citations93
US7867734B2Jan 11, 2011
Anti-glypican 3 antibody having modified sugar chain
CHUGAI PHARMACEUTICAL CO LTD23 citations91
US11001643B2May 11, 2021
Cytotoxicity-inducing therapeutic agent
CHUGAI PHARMACEUTICAL CO LTD9 citations84
US11505605B2Nov 22, 2022
T cell-redirected antigen-binding molecule for cells having immunosuppression function
CHUGAI PHARMACEUTICAL CO LTD3 citations70
US11072666B2Jul 27, 2021
Cell injury inducing therapeutic drug for use in cancer therapy
CHUGAI PHARMACEUTICAL CO LTD6 citations70
US11793180B2Oct 24, 2023
Gene-modified mouse expressing human GPC3 polypeptide
CHUGAI PHARMACEUTICAL CO LTD2 citations66
US12522669B2Jan 13, 2026
Cytotoxicity-inducing therapeutic agent
CHUGAI PHARMACEUTICAL CO LTD0 citations61
US12479929B2Nov 25, 2025
Cytotoxicity-inducing therapeutic agent
CHUGAI PHARMACEUTICAL CO LTD0 citations61
US11612149B2Mar 28, 2023
Non-human animal having human CD3 gene substituted for endogenous CD3 gene
CHUGAI PHARMACEUTICAL CO LTD0 citations56